Lab finder: therascreen PIK3CA RGQ PCR Kit – the companion diagnostic for PIQRAY (alpelisib)

Companion diagnostics analyze a patient's DNA or RNA for actionable genetic alterations in order to help determine what treatment options may be best. Companion diagnostics are:

  • FDA-approved for IVD use
  • Sensitive tests that are clinically validated for specific targeted therapies for specific cancers
Female indian doctor, consulting

The therascreen PIK3CA RGQ PCR Kit is a companion diagnostic test for use as an aid in identifying patients with advanced breast cancer for whom treatment with PIQRAY (alpelisib) may be appropriate.

The kit is a qualitative assay that can yield results in less than two working days. To find a lab that provides testing using the therascreen PIK3CA RGQ PCR Kit, please see the list of labs below and keep in mind this resource:

  • Is updated frequently, so continue to check back regularly for the most up-to-date information
  • May not represent all of the labs that offer the therascreen PIK3CA RGQ PCR Kit
  • May not represent each location of the labs below, contact the lab of interest to find the nearest location

If you are a lab that offers the therascreen PIK3CA RGQ PCR Kit and don’t see your lab listed below, please contact your QIAGEN sales representative or contact QIAGEN at 800-426-8157, option 1.

Labs that provide testing of clinical FFPE breast tumor tissue using the therascreen PIK3CA RGQ PCR Kit
QIAGEN has a broad portfolio of companion diagnostic products in development.
MORE INFORMATION
The therascreen PIK3CA RGQ PCR Kit is for in vitro diagnostic use.